SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 8th, 2019 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 8th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) dated as of October 1, 2019, by and between Propanc Biopharma Inc., a Delaware corporation, with headquarters located at 302, 6 Bulter Street, Camberwell, VIC 3124, Australia (the “Company”), and [●] (the “Buyer”).